|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/17/2013 9:33:22 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--NinePoint Medical, Inc., an emerging leader in the development of medical devices for in vivo imaging, today announced that data demonstrating positive results related to a new tethered capsule endomicroscopy technology, licensed from Massachusetts General Hospital (MGH), were published online this week in the journal Nature Medicine. The research, performed at the Wellman Center for Photomedicine at MGH, where the technology was developed, shows the pill-sized imaging system creates detailed, microscopic, three-dimensional images of the esophageal wall and is expected to offer several advantages over traditional endoscopy. This tethered capsule endomicroscopy technology has been licensed for commercial development by NinePoint Medical, as part of its 2010 licensing agreement with MGH, the largest technology IP license in MGH history.
|
|
|
|
|
|
|
|
|
|
|